Accidental clozapine intoxication in a toddler: clinical and pharmacokinetic lessons learnt

Clinic and Polyclinic for Pediatrics and Adolescent Medicine, Carl Gustav Carus University, Dresden National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA Institute of Forensic Medicine, University Medical Center, Freiburg Poison Information Center VIZ-Freiburg, University Medical Center, Freiburg, Germany.
Journal of Clinical Pharmacy and Therapeutics (Impact Factor: 1.67). 11/2012; 38(2). DOI: 10.1111/jcpt.12022
Source: PubMed


What is known and objective:
Clozapine, a second generation antipsychotic which is relatively safe in overdose, has been used as an effective treatment alternative to traditional antipsychotics. The therapeutic use in children remains controversial. However, in accordance with the increasing prescription in adults, the accidental ingestion in childhood becomes more frequent. We report the youngest case of accidental clozapine ingestion.

Case summary:
A 13-month-old girl presented with acute respiratory insufficiency and coma of unknown origin. The medical history, laboratory and radiological assessment did not link to aetiology until an almost spontaneous arousal after 22 h pointed towards intoxication. The initial standard drug screening using immunoassay had been negative. Hence, liquid chromatography mass spectrometry/mass spectrometry (LC-MS/MS) was performed, and clozapine was detected with a serum concentration of 736 ng/mL.

What is new and conclusion:
This case illustrates the diagnostic and forensic pitfalls in a coma of unknown origin due to the limits of toxicological screening immunoassays. LC-MS/MS analysis by an established method showed clozapine metabolites (norclozapine and clozapine-N-oxide) are detectable for longer period, especially in urine, when compared with clozapine. The clinical course is presented in unique correlation with plasma and urine concentrations of clozapine and its metabolites. The elimination pattern of clozapine in toddlers is similar to adults, and the toxic dose was found to be lower when compared with school-age children and adults.

Download full-text


Available from: Volker Auwärter, Oct 05, 2015
113 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The inclusion interaction of sulfobutylether-β-cyclodextrin with clozapine was studied using flow injection chemiluminescence and molecular docking. By use of a homemade flow injection chemiluminescence model of lg[(I 0−I s)/I s] = lgK + nlg[C clozapine], the formation constant K, the stoichiometric ratio n, and thermodynamic parameters between sulfobutylether-β-cyclodextrin and clozapine were obtained. Results showed that the inclusion forming process of sulfobutylether-β-cyclodextrin/clozapine with a stoichiometric ratio of 1:1 was spontaneous through hydrophobic interaction. The molecular docking results showed that clozapine entered into the cavity of sulfobutylether-β-cyclodextrin with one hydrogen bond. Based on the good linear relationship of quenching of chemiluminescence intensity versus the logarithm of concentration between 0.07 and 50.0 ng mL−1, a flow injection chemiluminescence method for clozapine was established for the first time with a detection limit of 0.02 ng mL−1 (3σ). The proposed method was successfully applied for the determination of clozapine in spiked human urine and serum samples, with recoveries from 92.1–108.2% and relative standard deviations less than 2.7%.
    Instrumentation Science & Technology 01/2014; 42(1). DOI:10.1080/10739149.2013.834449 · 0.54 Impact Factor